{"id":8636,"date":"2024-03-26T10:32:03","date_gmt":"2024-03-26T08:32:03","guid":{"rendered":"https:\/\/www.easistent.ro\/?p=8636"},"modified":"2024-04-19T09:18:54","modified_gmt":"2024-04-19T07:18:54","slug":"ziua-internationala-de-constientizare-a-infectiei-cu-hpv-4-martie","status":"publish","type":"post","link":"https:\/\/www.easistent.ro\/?p=8636","title":{"rendered":"Ziua Interna\u021bional\u0103 de Con\u0219tientizare a Infec\u021biei cu HPV: 4 martie"},"content":{"rendered":"\n<p><em>Timp aprox. de lectur\u0103: 5 minute<\/em><\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><a href=\"https:\/\/www.easistent.ro\/new\/wp-content\/uploads\/2024\/03\/hpv.jpg\"><img width=\"1024\" height=\"752\" src=\"https:\/\/www.easistent.ro\/new\/wp-content\/uploads\/2024\/03\/hpv.jpg\" alt=\"\" class=\"wp-image-8619\" srcset=\"https:\/\/www.easistent.ro\/new\/wp-content\/uploads\/2024\/03\/hpv.jpg 1024w, https:\/\/www.easistent.ro\/new\/wp-content\/uploads\/2024\/03\/hpv-300x220.jpg 300w, https:\/\/www.easistent.ro\/new\/wp-content\/uploads\/2024\/03\/hpv-768x564.jpg 768w, https:\/\/www.easistent.ro\/new\/wp-content\/uploads\/2024\/03\/hpv-80x60.jpg 80w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure><\/div>\n\n\n\n<p>Datele disponibile ne arat\u0103 c\u0103 infec\u021bia cu HPV cauzeaz\u0103 aproximativ 5% din totalul cazurilor de cancer la nivel mondial \u0219i aproximativ 2,5% din totalul cazurilor de cancer din Europa, iar 87.000 de cazuri de cancer la nivelul \u00eentregii regiuni europene a Organiza\u021biei Mondiale a S\u0103n\u0103t\u0103\u021bii sunt cauzate de infec\u021bia cu HPV.<\/p>\n\n\n\n<p>Cea mai comun\u0103 afec\u021biune oncologic\u0103 asociat\u0103 infec\u021biei cu HPV este cancerul de col uterin, dar acest virus este implicat \u0219i \u00een cancere mult mai rar \u00eent\u00e2lnite, precum cele ale organelor genitale (penis, vagin, vulv\u0103), cancerele anale, precum \u0219i unele cancere de la nivelul capului \u0219i g\u00e2tului.<\/p>\n\n\n\n<p>Dac\u0103 ne uit\u0103m la \u021b\u0103rile Uniunii Europene (UE), \u00een anul 2022, cancerul de col uterin a reprezentat al treilea cel mai des \u00eent\u00e2lnit cancer \u00een r\u00e2ndul femeilor din categoria de v\u00e2rst\u0103 activ\u0103, 15 \u2013 49 de ani. \u00cen UE, rata de inciden\u021b\u0103 standardizat\u0103 \u00een func\u021bie de v\u00e2rst\u0103 a cancerului de col uterin variaz\u0103 considerabil, de la cea mai mic\u0103 &#8211; 5,2 cazuri la 100.000 de locuitori de sex feminin \u00een Malta, la cea mai mare &#8211; <strong>32,6 cazuri la 100.000 de locuitori de sex feminin \u00een Rom\u00e2nia.<\/strong><\/p>\n\n\n\n<p>\u00cen aceste condi\u021bii, Organiza\u021bia Mondial\u0103 a S\u0103n\u0103t\u0103\u021bii a definit o strategie global\u0103 de eliminare a cancerului de col uterin care \u00ee\u0219i propune: o viziune a unei lumi \u00een care cancerul de col uterin este eliminat ca o problem\u0103 de s\u0103n\u0103tate public\u0103.<\/p>\n\n\n\n<p>Aceasta implic\u0103 un prag de <strong>4 la 100 000 de femei\/an<\/strong> bazat pe urm\u0103toarele <strong>obiective care trebuie \u00eendeplinite p\u00e2n\u0103 \u00een 2030<\/strong>, pentru ca \u021b\u0103rile s\u0103 fie <strong>pe<\/strong> <strong>calea elimin\u0103rii cancerului de col uterin<\/strong>:<\/p>\n\n\n\n<ul><li>90% dintre fete complet vaccinate cu vaccinul HPV p\u00e2n\u0103 la v\u00e2rsta de 15 ani.<\/li><li>70% dintre femei sunt depistate cu un test de \u00eenalt\u0103 performan\u021b\u0103 p\u00e2n\u0103 la v\u00e2rsta de 35 de ani \u0219i din nou p\u00e2n\u0103 la 45 de ani.<\/li><li>90% dintre femeile identificate cu boal\u0103 de col uterin primesc tratament (90% dintre femeile cu pre cancer tratate \u0219i 90% dintre femeile cu cancer invaziv gestionate).<\/li><\/ul>\n\n\n\n<p>\u00cen ceea ce prive\u0219te situa\u021bia din Rom\u00e2nia, o serie de m\u0103suri urm\u0103resc s\u0103 o \u00eembun\u0103t\u0103\u021beasc\u0103 prin cre\u0219terea accesului la vaccinarea anti-HPV. De exemplu, din luna decembrie 2023, vaccinarea \u00eempotriva infec\u021biilor cu HPV se poate face \u00een regim compensat extins, astfel<a href=\"#_ftn1\">[1]<\/a>: 100% pentru fete \u0219i b\u0103ie\u021bi cu v\u00e2rsta \u00eentre 11 \u0219i 18 ani, pe baza unei re\u021bete compensate eliberat\u0103 de medici de toate specialit\u0103\u021bile, afla\u021bi \u00een contract cu casele de asigur\u0103ri de s\u0103n\u0103tate; 50% pentru femeile cu v\u00e2rsta \u00eentre 19 \u015fi 45 de ani, pe baza unei re\u021bete compensate eliberat\u0103 de medici de toate specialit\u0103\u021bile, afla\u021bi \u00een contract cu casele de asigur\u0103ri de s\u0103n\u0103tate.&nbsp;<\/p>\n\n\n\n<p>Cu toate acestea \u0219i \u00een pofida unei tendin\u021be u\u0219or \u00eembun\u0103t\u0103\u021bite de acceptare \u00een ultimii ani, rata de vaccinare anti-HPV \u00een \u021bara noastr\u0103 r\u0103m\u00e2ne la un nivel suboptim raportat la \u021bintele propuse \u00een Planul Na\u021bional pentru Prevenirea \u0219i Combaterea Cancerului (30% \u00een anul 2025 \u0219i 40% \u00een anul 2030) \u0219i&nbsp; cu at\u00e2t mai mult fa\u021b\u0103 de Planul European de Combatere a Cancerului (care sus\u021bine \u021bintele OMS de eliminare a cancerelor cauzate de infec\u021bia cu HPV prin cre\u0219terea ratelor de vaccinare anti-HPV p\u00e2n\u0103 la 90%).<\/p>\n\n\n\n<p>Iat\u0103 de ce interven\u021bii suplimentare merit\u0103 ini\u021biate. \u00cen acest sens, merit\u0103 amintit faptul c\u0103&nbsp; Rom\u00e2nia ar putea accesa finan\u021b\u0103ri ce sunt puse la dispozi\u021bia \u021b\u0103rilor membre de Comisia European\u0103 pentru a sus\u021bine cre\u0219terea ratelor de vaccinare \u00eempotriva HPV \u0219i care ar putea-o ajuta s\u0103 p\u0103r\u0103seasc\u0103 aceast\u0103 <strong>nefast\u0103<\/strong> <strong>prim\u0103 pozi\u021bie \u00een r\u00e2ndul statelor din Uniunea European\u0103, \u00een ceea ce prive\u0219te inciden\u021ba \u0219i mortalitatea provocat\u0103 de cancerul de col uterin.<\/strong><\/p>\n\n\n\n<p><em>Mirela Musta\u021b\u0103, Redactor executiv E-asistent<\/em><\/p>\n\n\n\n<p>Surse de documentare<\/p>\n\n\n\n<ol type=\"1\"><li><a rel=\"noreferrer noopener\" href=\"https:\/\/www.statnews.com\/2023\/11\/08\/hpv-vaccines-cancer-screenings\/\" target=\"_blank\">https:\/\/www.statnews.com\/2023\/11\/08\/hpv-vaccines-cancer-screenings\/<\/a><\/li><li><a rel=\"noreferrer noopener\" href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240014107\" target=\"_blank\">Global strategy to accelerate the elimination of cervical cancer as a public health problem (who.int)<\/a><\/li><li><a rel=\"noreferrer noopener\" href=\"https:\/\/www.askabouthpv.org\/#:~:text=4th%20March%202024&amp;text=This%20site%20provides%20information%20to,and%20reduce%20your%20cancer%20risks.\" target=\"_blank\">HPV Awareness Day 2024 | International HPV Awareness DayHPV Campaign (askabouthpv.org)<\/a><\/li><li>EU Science Hub. 2020 Cancer incidence and mortality in EU-27 countries. <a rel=\"noreferrer noopener\" href=\"https:\/\/ec.europa.eu\/jrc\/en\/news\/2020-cancer-incidence-and-mortality-eu-27-countries\" target=\"_blank\">https:\/\/ec.europa.eu\/jrc\/en\/news\/2020-cancer-incidence-and-mortality-eu-27-countries<\/a>;<\/li><li>ANNEX to the Commission Implementing Decision on the financing of the Programme for the Union\u2019s action in the field of health (\u2018EU4Health Programme\u2019) and the adoption of the work programme for 2024, C(2023) 8524 final (2023) European Commission. pp 15-18. Available at: <a rel=\"noreferrer noopener\" href=\"https:\/\/health.ec.europa.eu\/system\/files\/2023-12\/funding_c_2023_8524_annex1_en.pdf\" target=\"_blank\">https:\/\/health.ec.europa.eu\/system\/files\/2023-12\/funding_c_2023_8524_annex1_en.pdf<\/a><\/li><li>De Martel C, Ferlay J, Franceschi S, et al. 2012. \u201cGlobal burden of cancers attributable to infections in 2008: A review and syntheticanalysis\u201c. Lancet Oncology 2012; 13(6):607-615. Available at:https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22575588;<\/li><li><a href=\"https:\/\/ecis.jrc.ec.europa.eu\/explorer.php?$0-0$1-RO$2-All$4-1,2$3-All$6-0,85$5-2022,2022$7-7$CEstByCancer$X0_8-3$CEstRelativeCanc$X1_8-3$X1_9-AE27$CEstBySexByCancer$X2_8-3$X2_-1-1\">https:\/\/ecis.jrc.ec.europa.eu\/explorer.php<\/a><\/li><li>Sursa foto: <a rel=\"noreferrer noopener\" href=\"https:\/\/tbrhsc.net\/get-the-correct-facts-about-hpv\/\" target=\"_blank\">Get the correct facts about HPV (tbrhsc.net)<\/a><\/li><\/ol>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<p><a href=\"#_ftnref1\">[1]<\/a> Monitorul Oficial al Rom\u00e2niei, Partea I, Nr. 1082\/29.XI.2023, protocolul terapeutic corespunz\u0103tor pozi\u021biei nr. 355 cod (J07BM03): DCI VACCIN PAPILOMAVIRUS.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Timp aprox. de lectur\u0103: 5 minute Datele disponibile ne arat\u0103 c\u0103 infec\u021bia cu HPV cauzeaz\u0103 aproximativ 5% din totalul cazurilor de cancer la nivel mondial \u0219i aproximativ 2,5% din totalul cazurilor de cancer din Europa, iar 87.000 de cazuri de cancer la nivelul \u00eentregii regiuni europene a Organiza\u021biei Mondiale a S\u0103n\u0103t\u0103\u021bii sunt cauzate de infec\u021bia [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":8619,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[152,6],"tags":[],"_links":{"self":[{"href":"https:\/\/www.easistent.ro\/index.php?rest_route=\/wp\/v2\/posts\/8636"}],"collection":[{"href":"https:\/\/www.easistent.ro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.easistent.ro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.easistent.ro\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.easistent.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8636"}],"version-history":[{"count":2,"href":"https:\/\/www.easistent.ro\/index.php?rest_route=\/wp\/v2\/posts\/8636\/revisions"}],"predecessor-version":[{"id":8638,"href":"https:\/\/www.easistent.ro\/index.php?rest_route=\/wp\/v2\/posts\/8636\/revisions\/8638"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.easistent.ro\/index.php?rest_route=\/wp\/v2\/media\/8619"}],"wp:attachment":[{"href":"https:\/\/www.easistent.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8636"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.easistent.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8636"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.easistent.ro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}